Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39071
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLOIX, Melanie-
dc.contributor.authorVANHERLE, Sarah-
dc.contributor.authorPunt, M.-
dc.contributor.authorVan Wouw, S.-
dc.contributor.authorDistel, B.-
dc.contributor.authorElgersma, Y.-
dc.contributor.authorHAIDAR, Mansour-
dc.contributor.authorZelcer, N.-
dc.contributor.authorHENDRIKS, Jerome-
dc.contributor.authorBOGIE, Jeroen-
dc.date.accessioned2022-12-19T08:44:17Z-
dc.date.available2022-12-19T08:44:17Z-
dc.date.issued2022-
dc.date.submitted2022-12-09T13:43:54Z-
dc.identifier.citationMultiple Sclerosis Journal, 28 (S3) , p. 1001-
dc.identifier.urihttp://hdl.handle.net/1942/39071-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleUBE3A inhibits remyelination by targeting ABCA1 for degradation-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 26-28, 2022-
local.bibliographicCitation.conferencename38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-
local.bibliographicCitation.conferenceplaceAmsterdam, NETHERLANDS-
dc.identifier.issueS3-
dc.identifier.spage1001-
dc.identifier.volume28-
local.bibliographicCitation.jcatM-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrEP1237-
dc.identifier.isi000866540804026-
local.provider.typewosris-
local.description.affiliation[Loix, M.; Vanherle, S.; Haidar, M.; Hendriks, J.; Bogie, J.] Hasselt Unvers, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium.-
local.description.affiliation[Punt, M.; Distel, B.; Elgersma, Y.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.-
local.description.affiliation[Van Wouw, S.; Zelcer, N.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands.-
local.uhasselt.internationalyes-
item.accessRightsOpen Access-
item.fullcitationLOIX, Melanie; VANHERLE, Sarah; Punt, M.; Van Wouw, S.; Distel, B.; Elgersma, Y.; HAIDAR, Mansour; Zelcer, N.; HENDRIKS, Jerome & BOGIE, Jeroen (2022) UBE3A inhibits remyelination by targeting ABCA1 for degradation. In: Multiple Sclerosis Journal, 28 (S3) , p. 1001.-
item.fulltextWith Fulltext-
item.contributorLOIX, Melanie-
item.contributorVANHERLE, Sarah-
item.contributorPunt, M.-
item.contributorVan Wouw, S.-
item.contributorDistel, B.-
item.contributorElgersma, Y.-
item.contributorHAIDAR, Mansour-
item.contributorZelcer, N.-
item.contributorHENDRIKS, Jerome-
item.contributorBOGIE, Jeroen-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Pages from 13524585221126910.pdfPublished version53.99 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.